INDIUM IN-111 OXYQUINOLINE

Details

Stereochemistry	ACHIRAL
Molecular Formula	3C9H6NO.In
Molecular Weight	547.268
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[In+3].[O-]C1=C2N=CC=CC2=CC=C1.[O-]C3=C4N=CC=CC4=CC=C3.[O-]C5=C6N=CC=CC6=CC=C5

InChI

InChIKey=AEGSYIKLTCZUEZ-UHFFFAOYSA-K

InChI=1S/3C9H7NO.In/c3*11-8-5-1-3-7-4-2-6-10-9(7)8;/h3*1-6,11H;/q;;;+3/p-3

HIDE SMILES / InChI

Molecular Formula	In
Molecular Weight	114.818
Charge	3
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C9H6NO
Molecular Weight	144.15
Charge	-1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.drugbank.ca/drugs/DB09425 | https://www.drugs.com/mmx/indium-in-111-pentetate.html

Indium In-111 pentetate disodium is a radioactive diagnostic indicated for use in radionuclide cisternography. Decay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column. Indium In 111 pentetate ( 111In-DTPA) is indicated as an imaging agent in cisternography to study the flow of cerebrospinal fluid (CSF) in the brain, to diagnose abnormalities in CSF circulation, to assess and help localize the site of CSF leakage, and to test the patency of or localize blocks in CSF shunts.

Approval Year

Conditions

Condition	Modality	Highest Phase	Product
hydrocephalus 8 Sources: http://www.nuclearonline.org/PI/Nycomed%20%20Indium%20DTPA%20In%20111.pdf	Diagnostic	Approved 8429	MPI INDIUM DTPA IN 111 Approved Use Unknown Launch Date 3.82751998E11
syringomyelia 8 Sources: http://www.nuclearonline.org/PI/Nycomed%20%20Indium%20DTPA%20In%20111.pdf	Diagnostic	Approved 8429	MPI INDIUM DTPA IN 111 Approved Use Unknown Launch Date 3.82751998E11
arachnoid cyst 8 Sources: http://www.nuclearonline.org/PI/Nycomed%20%20Indium%20DTPA%20In%20111.pdf	Diagnostic	Approved 8429	MPI INDIUM DTPA IN 111 Approved Use Unknown Launch Date 3.82751998E11

Sample Use Guides

In Vivo Use Guide

The maximum recommended intrathecal dose in the average patient (70 kg) is 18.5 MBq, 500 μCi. The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration.

Route of Administration: Other

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:42:27 UTC 2023` Edited by `admin` on `Fri Dec 15 15:42:27 UTC 2023`
Record UNII	LGX9OL562T
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

INDIUM IN-111 OXYQUINOLINE

Common Name

English

INDIUM OXINE IN 111

Brand Name

English

TRIS(8-QUINOLINOLATO-N1,O8)-INDIUM 111-IN

Common Name

English

INDIUM-111IN, TRIS(8-QUINOLINOLATO-.KAPPA.N1,.KAPPA.O8)-

Systematic Name

English

INDIUM IN 111 OXYQUINOLINE [USP IMPURITY]

Common Name

English

INDIUM (111 IN) OXYQUINOLINE

Common Name

English

Indium (111 in) oxyquinoline [WHO-DD]

Common Name

English

INDIUM IN-111 OXINE

Common Name

English

INDIUM IN-111 OXYQUINOLINE [ORANGE BOOK]

Common Name

English

INDIUM IN 111 OXYQUINOLINE

Official Name

English

INDIUM-111IN, TRIS(8-QUINOLINOLATO-N1,O8)-

Systematic Name

English

INDIUM IN 111 OXYQUINOLINE [USAN]

Common Name

English

INDIUM (111IN) OXINE

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C2124